Prospects and challenges of CRISPR/Cas9 gene-editing technology in cancer research

被引：3
|
作者：
Ning, Li [1 ,2 ]
Xi, Jiahui [1 ,2 ]
Zi, Yin [1 ,2 ]
Chen, Min [1 ,2 ]
Zou, Qingjian [1 ,2 ]
Zhou, Xiaoqing [1 ,2 ]
Tang, Chengcheng [1 ,2 ]
机构：
[1] Wuyi Univ, South China Inst Large Anim Models Biomed, Sch Biotechnol & Hlth Sci, Guangdong Prov Key Lab Large Anim Models Biomed, Jiangmen 529000, Peoples R China
[2] Int Healthcare Innovat Inst Jiangmen, Jiangmen, Peoples R China
来源：
CLINICAL GENETICS | 2023年 / 104卷 / 06期
关键词：
cancer; gene-editing; CRISPR/Cas9; gene therapy; immunotherapy; T-CELLS; CAS9; RIBONUCLEOPROTEIN; GENOMIC DNA; DELIVERY; BASE; IDENTIFICATION; BACTERIA; EFFICACY; REPEATS; SYSTEMS;
D O I：
10.1111/cge.14424
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Cancer, one of the leading causes of death, usually commences and progresses as a result of a series of gene mutations and dysregulation of expression. With the development of clustered regularly interspaced palindromic repeat (CRISPR)/Cas9 gene-editing technology, it is possible to edit and then decode the functions of cancer-related gene mutations, markedly advance the research of biological mechanisms and treatment of cancer. This review summarizes the mechanism and development of CRISPR/Cas9 gene-editing technology in recent years and describes its potential application in cancer-related research, such as the establishment of human tumor disease models, gene therapy and immunotherapy. The challenges and future development directions are highlighted to provide a reference for exploring pathological mechanisms and potential treatment protocols of cancer.
引用
收藏
页码：613 / 624
页数：12
相关论文
共 50 条
  • [41] Optical Control of CRISPR/Cas9 Gene Editing
    Hemphill, James
    Borchardt, Erin K.
    Brown, Kalyn
    Asokan, Aravind
    Deiters, Alexander
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (17) : 5642 - 5645
  • [42] Spatiotemporal control of CRISPR/Cas9 gene editing
    Chenya Zhuo
    Jiabin Zhang
    Jung-Hwan Lee
    Ju Jiao
    Du Cheng
    Li Liu
    Hae-Won Kim
    Yu Tao
    Mingqiang Li
    Signal Transduction and Targeted Therapy, 6
  • [43] Nobel Prize in Chemistry 2020 for gene editing with CRISPR/Cas9 technology
    Luthy, Isabel A.
    Lamb, Caroline A.
    MEDICINA-BUENOS AIRES, 2020, 80 (06) : 738 - 740
  • [44] GENE EDITING IN CHONDROCYTES USING CRISPR/CAS9
    Gibson, G.
    Yang, M.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S2 - S3
  • [45] Spatiotemporal control of CRISPR/Cas9 gene editing
    Zhuo, Chenya
    Zhang, Jiabin
    Lee, Jung-Hwan
    Jiao, Ju
    Cheng, Du
    Liu, Li
    Kim, Hae-Won
    Tao, Yu
    Li, Mingqiang
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [46] CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
    Miri, Seyed Mohammad
    Tafsiri, Elham
    Cho, William Chi Shing
    Ghaemi, Amir
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [47] How CRISPR/Cas9 Gene Editing Is Revolutionizing T Cell Research
    Johansen, Kristoffer Haurum
    DNA AND CELL BIOLOGY, 2022, 41 (01) : 53 - 57
  • [48] Establishment of an efficient early flowering-assisted CRISPR/Cas9 gene-editing system in Arabidopsis
    Kangwen Lao
    Yinlin Xiao
    Qing Huang
    Beixin Mo
    Xianxin Dong
    Xiaoyan Wang
    Plant Cell Reports, 2023, 42 : 211 - 214
  • [49] CRISPR/Cas9 for genome editing: progress, implications and challenges
    Zhang, Feng
    Wen, Yan
    Guo, Xiong
    HUMAN MOLECULAR GENETICS, 2014, 23 : R40 - R46
  • [50] Establishment of an efficient early flowering-assisted CRISPR/Cas9 gene-editing system in Arabidopsis
    Lao, Kangwen
    Xiao, Yinlin
    Huang, Qing
    Mo, Beixin
    Dong, Xianxin
    Wang, Xiaoyan
    PLANT CELL REPORTS, 2023, 42 (01) : 211 - 214
12345